Click for best price
ChemotherapyInduced Nausea Vomiting CINV Market Size, Share 2023
The global Chemotherapy-Induced Nausea and Vomiting (CINV) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Chemotherapy-Induced Nausea and Vomiting (CINV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Chemotherapy-Induced Nausea and Vomiting (CINV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Chemotherapy-Induced Nausea and Vomiting (CINV) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
This report aims to provide a comprehensive presentation of the global market for Chemotherapy-Induced Nausea and Vomiting (CINV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy-Induced Nausea and Vomiting (CINV).
This report contains market size and forecasts of Chemotherapy-Induced Nausea and Vomiting (CINV) in global, including the following market information:
- Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
We surveyed the Chemotherapy-Induced Nausea and Vomiting (CINV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, by Type, 2022 (%)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Chemotherapy-Induced Nausea and Vomiting (CINV) revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Chemotherapy-Induced Nausea and Vomiting (CINV) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Eisai
- ProStrakan
- Helsinn Holding
- Mundipharma
- Qilu Pharma
- Teva
- Novartis
- Heron Therapeutics
- Roche
- Mylan
- Tesaro
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chemotherapy-Induced Nausea and Vomiting (CINV), market overview.
Chapter 2: Global Chemotherapy-Induced Nausea and Vomiting (CINV) market size in revenue.
Chapter 3: Detailed analysis of Chemotherapy-Induced Nausea and Vomiting (CINV) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chemotherapy-Induced Nausea and Vomiting (CINV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Overall Market Size
2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size: 2022 VS 2030
2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players in Global Market
3.2 Top Global Chemotherapy-Induced Nausea and Vomiting (CINV) Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Companies
3.4 Top 3 and Top 5 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chemotherapy-Induced Nausea and Vomiting (CINV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting (CINV) Players in Global Market
3.6.1 List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Markets, 2022 & 2030
4.1.2 CINV
4.1.3 PONV
4.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2023
4.2.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2024-2030
4.2.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2023
5.2.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2024-2030
5.2.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2022 & 2030
6.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2023
6.2.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2024-2030
6.2.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.3.2 US Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.3.3 Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.3.4 Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.4.2 Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.3 France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.4 U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.5 Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.6 Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.7 Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.4.8 Benelux Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.5.2 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5.4 South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5.5 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.5.6 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.6.2 Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.6.3 Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030
6.7.2 Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.7.3 Israel Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.7.4 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
6.7.5 UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2018-2030
7 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.1.4 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.2.4 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 ProStrakan
7.3.1 ProStrakan Company Summary
7.3.2 ProStrakan Business Overview
7.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.3.4 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.3.5 ProStrakan Key News & Latest Developments
7.4 Helsinn Holding
7.4.1 Helsinn Holding Company Summary
7.4.2 Helsinn Holding Business Overview
7.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.4.4 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.4.5 Helsinn Holding Key News & Latest Developments
7.5 Mundipharma
7.5.1 Mundipharma Company Summary
7.5.2 Mundipharma Business Overview
7.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.5.4 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.5.5 Mundipharma Key News & Latest Developments
7.6 Qilu Pharma
7.6.1 Qilu Pharma Company Summary
7.6.2 Qilu Pharma Business Overview
7.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.6.4 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.6.5 Qilu Pharma Key News & Latest Developments
7.7 Teva
7.7.1 Teva Company Summary
7.7.2 Teva Business Overview
7.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.7.4 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.7.5 Teva Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.8.4 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Heron Therapeutics
7.9.1 Heron Therapeutics Company Summary
7.9.2 Heron Therapeutics Business Overview
7.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.9.4 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.9.5 Heron Therapeutics Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.10.4 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 Mylan
7.11.1 Mylan Company Summary
7.11.2 Mylan Business Overview
7.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.11.4 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.11.5 Mylan Key News & Latest Developments
7.12 Tesaro
7.12.1 Tesaro Company Summary
7.12.2 Tesaro Business Overview
7.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.12.4 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2018-2023)
7.12.5 Tesaro Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Opportunities & Trends in Global Market
Table 2. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers in Global Market
Table 3. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints in Global Market
Table 4. Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV) in Global Market
Table 5. Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chemotherapy-Induced Nausea and Vomiting (CINV) Product Type
Table 9. List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2024-2030
Table 30. Merck Company Summary
Table 31. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 32. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Eisai Company Summary
Table 35. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 36. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 37. Eisai Key News & Latest Developments
Table 38. ProStrakan Company Summary
Table 39. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 40. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 41. ProStrakan Key News & Latest Developments
Table 42. Helsinn Holding Company Summary
Table 43. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 44. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 45. Helsinn Holding Key News & Latest Developments
Table 46. Mundipharma Company Summary
Table 47. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 48. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 49. Mundipharma Key News & Latest Developments
Table 50. Qilu Pharma Company Summary
Table 51. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 52. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 53. Qilu Pharma Key News & Latest Developments
Table 54. Teva Company Summary
Table 55. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 56. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 60. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Heron Therapeutics Company Summary
Table 63. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 64. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 65. Heron Therapeutics Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 68. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. Mylan Company Summary
Table 71. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 72. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 73. Mylan Key News & Latest Developments
Table 74. Tesaro Company Summary
Table 75. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 76. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn) & (2018-2023)
Table 77. Tesaro Key News & Latest Developments
List of Figures
Figure 1. Chemotherapy-Induced Nausea and Vomiting (CINV) Segment by Type in 2022
Figure 2. Chemotherapy-Induced Nausea and Vomiting (CINV) Segment by Application in 2022
Figure 3. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2022
Figure 8. By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 16. US Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 20. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 21. France Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 28. China Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 32. India Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 34. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2018-2030
Figure 37. Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2018-2030
Figure 41. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
